mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
lapatinib |
UHNBreast |
pan-cancer |
AAC |
-0.1 |
0.7 |
mRNA |
GDC-0941 |
gCSI |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
BRD-K29086754 |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.7 |